AIDS Care: An Institutional Delivery Model,St. Paul's (Vancouver) Experience

AIDS Update, Laboratory Centre for Disease Control, Ottawa, March 19, 1987.

AIDS Update, Laboratory Centre for Disease Control, Ottawa, July 27, 1987.

Boyko W.J. , Schechter M.T. , Craib K.J.P. The Vancouver Lymphadenopathy-AIDS Study, Part V: Antecedent behavioural, clinical and laboratory parameters in AIDS patients versus HTLV-III positive controls. Can Med Assoc J 1986; 135: 881–7.

Boyko W.J. , Schechter M.T. , Jeffries E. , Douglas B. , Maynard M. , and O'Shaughnessy M. The Vancouver Lymphadenopathy-AIDS Study, Part III: Relation of HTLV-III seropositivity, immune status and lymphadenopathy. Can Med Assoc J 1985; 133: 28–32.

Goldstone I.L. , Bolding B. , and Beaufoy A. Caring for the AIDS patient. Registered Nurses’ Association of British Columbia News 1985; 17: 6, 11–12.

Jeffries E. , Willoughby B. , Boyko W.J. The Vancouver Lymphadenopathy-AIDS Study, Part II: Seroepidemiology of HTLV-III antibody. Can Med Assoc J 1985; 132: 1373–7.

McLeod W.A. , Smith T. , and Willoughby B. Hospice care of AIDS patients. J of Palliative Care 1986; 2(1): 33–34.

Rekart M. Verbal communication, May 13, 1987.

Schechter M.T. , Boyko W.J. , Douglas B. The Vancouver Lymphadenopathy-AIDS Study, Part VI: HIV seroconversion in a cohort of homosexual men. Can Med Assoc J 1986; 135: 1355–60.

Schechter M.T. , Boyko W.J. , Jeffries E. , Willoughby B. , Nitz R. , and Constance P. The Vancouver Lymphadenopathy-AIDS Study, Part I: Persistent generalized lymphadenopa-thy. Can Med Assoc J 1985; 132: 1273–9.

Schechter M.T. , Boyko W.J. , Jeffries E. The Vancouver Lymphadenopathy-AIDS Study, Part IV: Effects of exposure factors, co-factors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J 1985; 133: 286–92.

McLean H.E. Dr , Consultant, Communicable Diseases, Vancouver Health Department. Verbal communication, July 22, 1987.